| E-Mail | |
 : 
English version
 

III . I:


III II 25 (18 ) 19 73 .

Annotation
To study in detail electrophysiological properties of Niferidil, a novel III-class antiarrhythmic manufactured in Russia, 25 patients including 18 men aged 19 73 years with documented paroxysms of supraventricular tachycardia were examined during a Phase II clinical trial.



, . ., , . ., , . ., , . ., , . ., , . ., , . ., , . ., , . .


-70 01/12/2012, . 5 /..



PDFs








-

ISSN 1561-8641

: 0
© Copyright " ", 1993-2020